Process for the preparation of optically pure diastereoisomers of tetrahydrofolate compounds using 10-formyltetrahydrofolate synthetase from clostridium
AssigneeAmerican Cyanamid Company
InventorsGerhard Schlingmann, Stuart A. Rosenfeld
Life of this patent
Estimating the term…
Abstract
A process for the preparation of optically pure diastereoisomers of tetrahydrofolate compounds is described, comprising the conversion, for example, of only the 5,6S,7,8-tetrahydrofolic acid component of a racemic mixture of 5,6,7,8-tetrahydrofolic acid to 10-formyl-5,6S,7,8-tetrahydrofolic acid in the presence of a formyl tetrahydrofolate synthetase, followed by cyclizing, hydrolyzing and derivatizing. The process is also useful to make a desired substantially pure (6R or 6S) enantiomer of a derivative of (radiolabeled) tetrahydrofolic acid or a salt or ester thereof.
Claims1
A process for preparing a substantially pure calcium salt of 5-formyl-5, 6S,7,8-tetrahydrofolic acid, which process comprises the steps of:
- (a) enzymatically formylating the 6S form of a mixture of 6R and 6S diastereoisomers of 5,6,7,8-tetrahydrofolic acid utilizing a tetrahydrofolate formylase enzyme elaborated by Clostridium sp. ATCC No. 7905 or a mutant thereof so as to form a mixture comprising 10-formyl-5,6S,7,8-tetrahydrofolic acid;
- unreacted 5,6S,7,8-tetrahydrofolic acid and unreacted 5,6R,7,8-tetrahydrofolic acid;
- (b) cyclizing said 10-formyl-5,6S, 7,8-tetrahydrofolic acid form 5,10-methenyl-5,6S, 7,8-tetra hydrofolic acid and hydrolyzing and 5,10-methenyl-5,6S,7,8 tetrahydrofolic acid to form 5-formyl-5,6S, 7,8-tetrahydrofolic acid, wherein said cyclizing and hydrolyzihng steps are conducted in the presence of 5,6R,7,8-tetrahydrofolic acid;
- (c) separating the 5-formyl-5,6S, 7,8-tetrahydrofolic acid form 5,10-menthenyl- 5,6S, 7,8-tetra hydrofolic acid and 5,6R, 7,8-tetrahydrofolic acid by reverse phase chromatographic separation, and developed with a gradient of 0.1M aqueous formic acid and methanol;
- (d) converting the substantially pure 5-formyl-5,6-S,7,8-tetrahydrofolic acid to the corresponding calcium salt using calcium chloride or a chemical equivalent thereof.
Dependencies are inferred from the claim text.